Professor Thomas J Peto
Podcast interview
Malaria elimination and mass drug administration

Although malaria has greatly declined in Southeast Asia this century, treating clinical cases won’t be sufficient to eliminate it from the region. Mass drug administration allows to eliminate parasites from asymptomatic carriers, and careful engagement with whole communities is key.
Thomas Peto
MPH, PhD
Associate Professor
Malaria
I am an epidemiologist at the Mahidol Oxford Tropical Medicine Research Unit, based in the Malaria and Critical Illness department. I work in rural areas to study malaria epidemiology and conduct clinical trials to evaluate malaria treatment and elimination strategies in Southeast Asia and Africa. I study new artemisinin combination therapies, antimalarial drug resistance, and population-level interventions to address the hidden reservoir of asymptomatic malaria infections. I also work on various epidemiological studies to improve mortality and disease burden estimates in Southeast Asia, focused chiefly on acute febrile illnesses and other infectious diseases.
Recent publications
Estimating enteric fever seroincidence in rural western Cambodia: findings from a population-based cross-sectional serosurvey.
Journal article
Zhang M. et al, (2026), medRxiv
Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria.
Journal article
Ding J. et al, (2026), Br J Clin Pharmacol, 92, 589 - 605
Circus arts shine a spotlight on antimicrobial resistance in Cambodia.
Journal article
Moul V. et al, (2026), Int Health
Acrobatics for Antibiotics: Exploring circus-based engagement on community practices surrounding antimicrobial resistance in Cambodia.
Journal article
Wijntuin R. et al, (2026), Wellcome Open Res, 11
Advances in population-based interventions to control falciparum malaria.
Journal article
Glossop SE. et al, (2025), Trans R Soc Trop Med Hyg, 119, 1316 - 1323
